WARNING:
•IN SOME CASES, FREQUENT AND PROLONGED MEASUREMENTS
CAN RESULT IN PETECHIA, ISCHEMIA, PURPURA, OR NEUROPATHY. CHECK THE CUFF SITE REGULARLY WHEN TAKING FREQUENT MEASUREMENTS OVER AN EXTENDED TIME PERIOD. ALSO CHECK FOR ANY SIGNS OF RESTRICTED CIRCULATION IN THE EXTREMITIES OF THE LIMB WHERE THE NBP CUFF IS WRAPPED.
•BE SURE THE
BLOCKED OR KINKED DURING A MEASUREMENT. A BLOCKED OR KINKED HOSE COULD LEAD TO EXCESSIVE PRESSURE IN
THE BLOOD PRESSURE CUFF, WHICH COULD CAUSE LIMB DAMAGE. IN THE EVENT THE CUFF NEEDS TO BE STOPPED DURING OPERATION DUE TO AN ERROR CREATED BY A BLOCKED OR KINKED HOSE, THE CUFF SHOULD BE REMOVED FROM THE ARM BY RELEASING THE VELCRO® STRAP OR PULLING/CUTTING THE HOSE OFF OF THE CONNECTOR.
10.PULSE OXIMETRY WARNINGS:
•REPOSITION THE PULSE OXIMETRY SENSOR AT LEAST EVERY 4
HOURS (2 HOURS FOR POORLY PERFUSED PATIENTS). MOVE THE SENSOR IF YOU SEE ANY SIGNS OF SKIN IRRITATION OR IMPAIRED CIRCULATION.
•ELEVATED LEVELS OF CARBOXYHEMOGLOBIN OR METHEMOGLOBIN
IN MONITORED PATIENTS CAN RESULT IN INACCURATE PULSE OXIMETRY READINGS.
•A PULSE OXIMETER SHOULD BE CONSIDERED AS AN
EARLY WARNING DEVICE. AS A TREND TOWARD PATIENT DEOXYGENATION IS INDICATED, BLOOD SAMPLES SHOULD BE ANALYZED BY A LABORATORY
11.PROBES AND CABLES ARE DESIGNED FOR USE WITH SPECIFIC MONITORS. VERIFY COMPATIBILITY AND USE ONLY APPROVED ACCESSORIES WITH VITALPOINT. USING
12.TO AVOID AN ELECTRICAL SHOCK HAZARD, THE CONDUCTIVE PART OF THE ELECTRODES SHOULD NOT BE ALLOWED TO COME IN CONTACT WITH OTHER CONDUCTIVE OBJECTS, INCLUDING EARTH.
13.DO NOT INTRODUCE ANY ADDITIONAL PATIENT CONNECTION THAT MAY PRODUCE ELECTRICAL CURRENT. VITALPOINT APPLIES APPROXIMATELY 2 MICROAMPERES (2 µA).
14.ACCESSORIES SHOULD BE DISPOSED OF ACCORDING TO THE MANUFACTURER’S INSTRUCTIONS ON PACKAGING.